No data available.
No data available.
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | ABT | Abbott Laboratories | 173.80 Bn | 32.73 | 5.47 | 12.94 Bn |
| 2 | SYK | Stryker Corp | 141.15 Bn | 43.48 | 5.62 | 15.86 Bn |
| 3 | MDT | Medtronic plc | 123.47 Bn | 25.92 | 3.55 | 29.10 Bn |
| 4 | BSX | Boston Scientific Corp | 112.80 Bn | 38.92 | 5.62 | 11.44 Bn |
| 5 | EW | Edwards Lifesciences Corp | 45.66 Bn | 33.38 | 7.76 | 0.70 Bn |
| 6 | DXCM | Dexcom Inc | 27.52 Bn | 32.91 | 5.90 | 1.34 Bn |
| 7 | STE | STERIS plc | 24.13 Bn | 34.08 | 4.14 | 2.05 Bn |
| 8 | PODD | Insulet Corp | 17.33 Bn | 70.38 | 6.87 | 1.01 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 0.70 | 2.13 | |
| EV to Cash from Ops. EV/CFO | -9.78 | 2.75 | |
| EV to Debt EV to Debt | 2.40 | 17.25 | |
| EV to EBIT EV/EBIT | -59.74 | 2.89 | |
| EV to EBITDA EV/EBITDA | 41.75 | 4.53 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | -6.81 | 29.36 | |
| EV to Market Cap EV to Market Cap | 1.49 | 25.09 | |
| EV to Revenue EV/Rev | 1.70 | 32.80 | |
| Price to Book Value [P/B] P/B | 1.02 | 4.73 | |
| Price to Earnings [P/E] P/E | -11.45 | -2.04 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Dividend Coverage Ratio | 0.00 | 40.22 | |
| Dividend Payout Ratio % Div Payout % (Qtr) | 0.00 | 1.59 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.00 | 0.10 | |
| FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) | 0.00 | -0.37 | |
| Interest Coverage Int. cover (Qtr) | -1.30 | 196.93 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex 1y % (Qtr) | -29.83 | -152.08 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | 44.53 | 8,476.58 | |
| Dividend Growth (1y) % Dividend Growth (1y) % | 0.00 | -0.44 | |
| EBIAT Growth (1y) % EBIAT 1y % (Qtr) | -113.87 | -792.16 | |
| EBITDA Growth (1y) % EBITDA 1y % (Qtr) | -91.63 | 3.79 | |
| EBIT Growth (1y) % EBIT 1y % (Qtr) | -106.22 | -301.80 | |
| EBT Growth (1y) % EBT 1y % (Qtr) | -111.34 | -121.44 | |
| EPS Growth (1y) % EPS 1y % (Qtr) | -122.00 | -87.51 | |
| FCF Growth (1y) % FCF 1y % (Qtr) | -6.39 | 10.43 | |
| Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) | -5.20 | 38.21 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Util Ratio (Qtr) | 0.41 | 0.55 | |
| Cash Payout Ratio Cash Payout (Qtr) | 0.00 | 0.02 | |
| Cash Ratio Cash Ratio (Qtr) | 0.06 | 1.80 | |
| Current Ratio Curr Ratio (Qtr) | 1.71 | 4.18 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.63 | 1.20 | |
| Interest Cover Ratio Int Coverage (Qtr) | -1.30 | 196.93 | |
| Times Interest Earned Times Interest Earned (Qtr) | -1.30 | 196.93 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % (Qtr) | 1.90 | -2,396.63 | |
| EBIT Margin % EBIT Margin % (Qtr) | -2.85 | -2,478.60 | |
| EBT Margin % EBT Margin % (Qtr) | -5.03 | -2,690.42 | |
| Gross Margin % Gross Margin % (Qtr) | 86.90 | 30.80 | |
| Net Profit Margin % Net Margin % (Qtr) | -10.00 | -2,821.53 |